These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5474280)

  • 1. Quantitative thin-layer chromatographic estimation of labeled dopamine and norepinephrine, their precursors and metabolites.
    Fleming RM; Clark WG
    J Chromatogr; 1970 Oct; 52(2):305-12. PubMed ID: 5474280
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid effects of monoamine oxidase inhibitors on synthesis and release of central monoamines.
    Glowinski J; Hamon M; Javoy F; Morot-Gaudry Y
    Adv Biochem Psychopharmacol; 1972; 5():423-39. PubMed ID: 4403372
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of amphetamine on the contents of norepinephrine and its metabolites in the effluent of perfused cerebral ventricles of the cat.
    Carr LA; Moore KE
    Biochem Pharmacol; 1970 Jul; 19(7):2361-74. PubMed ID: 5520379
    [No Abstract]   [Full Text] [Related]  

  • 4. A new method for the determination of labeled DOPAMINE, norepinephrine and their metabolites in rat brain homogenate.
    Schweitzer JW; Friedhoff AJ
    Life Sci; 1969 Feb; 8(4):173-82. PubMed ID: 5777629
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of dopamine and noradrenaline in rabbit caudate nucleus in vitro.
    Jonason J; Rutledge CO
    Acta Physiol Scand; 1968 Aug; 73(4):411-7. PubMed ID: 5708171
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurochemical properties of adrenergic nerves regenerated after 6-hydroxydopamine.
    Jonsson G; Sachs C
    J Neurochem; 1972 Nov; 19(11):2577-85. PubMed ID: 5086245
    [No Abstract]   [Full Text] [Related]  

  • 7. Radioenzymatic assay for the simultaneous measurement of noradrenaline, dopamine and their non-O-methylated metabolites.
    Bardsley M; Bachelard HS
    Cell Mol Biol Incl Cyto Enzymol; 1981; 27(2-3):71-6. PubMed ID: 7296612
    [No Abstract]   [Full Text] [Related]  

  • 8. Presence of dopaminergic terminals and absence of dopaminergic cell bodies in the cerebral cortex of the cat.
    Thierry AM; Hirsch JC; Tassin JP; Blanc G; Glowinski J
    Brain Res; 1974 Oct; 79(1):77-88. PubMed ID: 4425954
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.
    Breese GR; Traylor TD
    J Pharmacol Exp Ther; 1970 Sep; 174(3):413-20. PubMed ID: 5456173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine: spontaneous and drug-induced release from the caudate nucleus in the cat.
    Besson M; Cheramy A; Feltz P; Glowinski J
    Brain Res; 1971 Sep; 32(2):407-24. PubMed ID: 4400012
    [No Abstract]   [Full Text] [Related]  

  • 11. Catecholamine metabolism in the dog: comparison of intravenously and intraventricularly administered [14C]dopamine and [3H]norepinephrine.
    Chase TN; Breese GR; Gordon EK; Kopin IJ
    J Neurochem; 1971 Jan; 18(1):135-40. PubMed ID: 5107962
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo inhibition of dopamine beta-hydroxylase by 1-phenyl-3-(2-thiazolyl)-2-thiourea (U-14,624).
    Johnson GA; Boukma SJ; Kim EG
    J Pharmacol Exp Ther; 1970 Jan; 171(1):80-7. PubMed ID: 5410940
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of ventromedial tegmental lesions on the disposition of dopamine in the caudate nucleus of the monkey.
    Goldstein M; Anagnoste B; Owen WS; Battista AF
    Brain Res; 1967 Mar; 4(2):298-300. PubMed ID: 4961813
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of noradrenaline, of dopamine and dihydroxyphenylacetic acid in certain nuclei of rat brain].
    Gérardy J; Quinaux N; Dresse A
    Experientia; 1971 Jan; 27(1):112-3. PubMed ID: 5552690
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recent acquisitions on cerebral metabolism of catecholamines].
    Glowinski J
    Actual Pharmacol (Paris); 1967; 20():29-68. PubMed ID: 4894123
    [No Abstract]   [Full Text] [Related]  

  • 16. Activities of monoamine metabolizing enzymes in rat salivary glands: a comparison between tissue slices and homogenates.
    Jonason J
    Acta Pharmacol Toxicol (Copenh); 1969; 27(1):73-80. PubMed ID: 5819501
    [No Abstract]   [Full Text] [Related]  

  • 17. Accumulation of dopamine in the parenchyma after decarboxylase inhibition in the capillaries of brain.
    Constantinidis J; Bartholini G; Tissot R; Pletscher A
    Experientia; 1968 Feb; 24(2):130-1. PubMed ID: 5643797
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of monoamine oxidase in determining the amount of monoamines released by drugs in the central nervous system.
    Rutledge CO; Azzaro AJ; Ziance RJ
    Adv Biochem Psychopharmacol; 1972; 5():379-92. PubMed ID: 5054209
    [No Abstract]   [Full Text] [Related]  

  • 19. Brain amine concentrations after monoamine oxidase inhibitor administration.
    Jones AB; Pare CM; Nicholson WJ; Price K; Stacey RS
    Br Med J; 1972 Jan; 1(5791):17-9. PubMed ID: 5008339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake and binding of catecholamines. Effect of diphenylhydantoin and a new mechanism of action.
    Hadfield MG
    Arch Neurol; 1972 Jan; 26(1):78-84. PubMed ID: 4257092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.